Nutlin-3(CAS: 890090-75-2)

Nutlin-3 (CAS: 890090-75-2) falls under the jurisdiction of several regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements for chemical safety. Manufacturers must ensure compliance with these guidelines for proper classification, labeling, and handling of the compound.

There are several alternatives to Nutlin-3 (CAS: 890090-75-2) that can be used in synthesis. Common analogs and isomers include analogs with modified substituents. Alternative reagents such as staurosporine and H10404 are often used as substitutes in various chemical reactions, depending on the specific application.

Nutlin-3 (CAS: 890090-75-2) shows strong research trends in the field of cancer treatment, particularly for its role as a p53 activator. Market demand is growing due to its potential in targeted cancer therapy. Additionally, there is increasing interest in its use in preclinical studies for developing novel anticancer drugs.

Waste containing Nutlin-3 (CAS: 890090-75-2) should be collected in a closed, labeled container and stored in a safe, secure area. Proper waste disposal should follow local regulations. For disposal, professional hazardous waste facilities should be contacted to handle the waste through incineration or other environmentally friendly methods to ensure compliance with environmental protection regulations.